Impact BioMedical Inc.
IBO
$0.43
-$0.01-1.60%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 89.76% | -1,032.36% | 95.33% | -737.99% | 579.03% |
| Total Depreciation and Amortization | 42,700.00% | 100.00% | -50.00% | 0.00% | 100.00% |
| Total Amortization of Deferred Charges | -298.60% | 1.42% | 1.81% | -0.72% | 0.36% |
| Total Other Non-Cash Items | -96.06% | 4,490.72% | -98.88% | 581.92% | -1,985.31% |
| Change in Net Operating Assets | 600.00% | -45.45% | 102.67% | -196.40% | -120.63% |
| Cash from Operations | 11.67% | -1.76% | 45.70% | -25.47% | -160.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | -- | -100.00% | 0.00% |
| Cash from Investing | -- | -100.00% | -- | -100.00% | 0.00% |
| Total Debt Issued | -- | -- | -- | 1,078.33% | -115.63% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -83.99% | 854.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.82% | -1.91% | -1.79% | -125.09% | -- |